logo

217.56

217.56 (-0.12%)

As of Mar 06, 2024

BIOGEN INC. [BIIB]

Source: 

Company Overview

Biogen is a global biopharmaceutical company focused on discovering, developing and delivering innovative therapies for people living with serious and complex diseases worldwide. We have a broad portfolio of medicines to treat multiple sclerosis (MS), have introduced the first approved treatment for spinal muscular atrophy (SMA) and co-developed two treatments to address a defining pathology of Alzheimer’s disease.

CountryUnited States
Headquarterscambridgemassachusetts
Phone Number7814642000
Industry
manufacturing
CEOChristopher A. Viehbacher
Websitewww.biogen.com